In endotoxemia and infectious disease models, Robo4 suppresses vascular hyperpermeability and mortality induced by lipopolysaccharide, Escherichia coli, influenza virus, and SARS-CoV-215,19,22, indicating that ROBO4 is a promising therapeutic target for infectious and inflammatory diseases. Here, ROBO4 is linked to serum lipopolysaccharide activity.